Olaplex (OLPX)
(Delayed Data from NSDQ)
$2.20 USD
+0.35 (18.65%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $2.20 +0.01 (0.23%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$2.20 USD
+0.35 (18.65%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $2.20 +0.01 (0.23%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth D Momentum C VGM
Zacks News
Here's What Key Metrics Tell Us About Olaplex (OLPX) Q2 Earnings
by Zacks Equity Research
Although the revenue and EPS for Olaplex (OLPX) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Olaplex Holdings, Inc. (OLPX) Q2 Earnings Meet Estimates
by Zacks Equity Research
Olaplex (OLPX) delivered earnings and revenue surprises of 0% and 0.99%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Olaplex (OLPX) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Olaplex (OLPX) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
What's in Store for International Flavors' (IFF) Q1 Earnings?
by Zacks Equity Research
International Flavors' (IFF) Q1 results are likely to reflect the impacts of lower volumes and escalating costs.
Coty (COTY) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Coty (COTY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Olaplex Holdings, Inc. (OLPX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Olaplex (OLPX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Olaplex Holdings, Inc. (OLPX) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Olaplex Holdings, Inc. (OLPX) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Olaplex Holdings, Inc. (OLPX) Q4 Earnings Meet Estimates
by Zacks Equity Research
Olaplex Holdings, Inc. (OLPX) delivered earnings and revenue surprises of 0% and 3.32%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Insights Into Olaplex Holdings, Inc. (OLPX) Q4: Wall Street Projections for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of Olaplex Holdings, Inc. (OLPX) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Earnings Preview: Olaplex Holdings, Inc. (OLPX) Q4 Earnings Expected to Decline
by Zacks Equity Research
Olaplex Holdings, Inc. (OLPX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Trends Redefining Beauty: What to Expect in 2024
by Ansuiya Mohta
Inter Parfums (IPAR), COTY, European Wax Center (EWCZ) and Olaplex (OLPX) are well-positioned to continue their growth story in 2024, backed by solid brand images and innovation efforts.
Olaplex Holdings, Inc. (OLPX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Olaplex Holdings, Inc. (OLPX) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Earnings Preview: Olaplex Holdings, Inc. (OLPX) Q3 Earnings Expected to Decline
by Zacks Equity Research
Olaplex Holdings, Inc. (OLPX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Do Options Traders Know Something About Olaplex (OLPX) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Olaplex (OLPX) stock based on the movements in the options market lately.
Olaplex Holdings, Inc. (OLPX) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Olaplex Holdings, Inc. (OLPX) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Olaplex Holdings, Inc. (OLPX) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Olaplex Holdings, Inc. (OLPX) delivered earnings and revenue surprises of -40% and 11.41%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Do Options Traders Know Something About Olaplex (OLPX) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Olaplex (OLPX) stock based on the movements in the options market lately.
Olaplex Holdings, Inc. (OLPX) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Olaplex Holdings, Inc. (OLPX) delivered earnings and revenue surprises of 25% and 3.11%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Are Options Traders Betting on a Big Move in Olaplex (OLPX) Stock?
by Zacks Equity Research
Investors need to pay close attention to Olaplex (OLPX) stock based on the movements in the options market lately.
Olaplex Holdings, Inc. (OLPX) Surpasses Q4 Earnings Estimates
by Zacks Equity Research
Olaplex Holdings, Inc. (OLPX) delivered earnings and revenue surprises of 16.67% and 1.39%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Nu Skin Enterprises (NUS) Q4 Earnings Surpass Estimates
by Zacks Equity Research
Nu Skin (NUS) delivered earnings and revenue surprises of 67.92% and 3.94%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Olaplex Holdings, Inc. (OLPX) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Olaplex Holdings, Inc. (OLPX) delivered earnings and revenue surprises of 10% and 0.11%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Olaplex Holdings, Inc. (OLPX) Q3 Earnings Expected to Decline
by Zacks Equity Research
Olaplex Holdings, Inc. (OLPX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Estee Lauder (EL) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Estee Lauder (EL) delivered earnings and revenue surprises of 6.20% and 0.34%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Natura &Co Holding S.A. ADR (NTCO) Soars 11.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Natura &Co Holding S.A. ADR (NTCO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.